US Patent Issued to SYNTHEKINE on Feb. 3 for "IL10RAlpha/IL2RGamma synthetic cytokines" (California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,188, issued on Feb. 3, was assigned to SYNTHEKINE INC. (Menlo Park, Calif.).

"IL10RAlpha/IL2RGamma synthetic cytokines" was invented by Robert Kastelein (Menlo Park, Calif.), Deepti Rokkam (Menlo Park, Calif.), Patrick J. Lupardus (Menlo Park, Calif.), Mahalakshmi Ramadass (Menlo Park, Calif.) and Sandro Vivona (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are IL10RAlpha/IL2RGamma binding molecules that bind to IL10RAlpha and IL2RGamma and comprise an anti-IL2RGamma sdAb and an anti-IL2RGamma VHH antibody."

The patent was filed on Aug. 6, 2021, under Application No. 18/017,838.

*For further information, includin...